Glucose-6-phosphate dehydrogenase deficiency and multiple sclerosis in northern Sardinia

HER-2 gene alterations as biomarker in patients with metastatic colorectal cancer treated with FOLFIRI + cetuximab: findings from the CAPRI-2 GOIM study.

ESMO gastrointestinal oncology·2026

Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial.

ESMO open·2025

Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study.

ESMO open·2023

A multicentre study on spontaneous in-cage activity and micro-environmental conditions of IVC housed C57BL/6J mice during consecutive cycles of bi-weekly cage-change.

PloS one·2022

NEPA (netupitant/palonosetron) for the antiemetic prophylaxis of nausea and vomiting induced by chemotherapy (CINV) with Folfirinox and Folfoxiri even during the COVID-19 pandemic: a real-life study.

European review for medical and pharmacological sciences·2021

Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Sex disparities in comorbidities, one-year functional outcome and mortality after ischemic stroke: a population-based study.

Neuroepidemiology·2026

Early cognitive instability predicts persistent decline: a 10 year longitudinal study in a rural, low resource community.

Neuroepidemiology·2026

Trends and Disparities in Dementia- and Sepsis-Related Mortality in Older U.S. Adults (1999-2020).

Neuroepidemiology·2026

Residential radon concentration and the risk of malignant brain and central nervous system cancer in United States postmenopausal women.

Neuroepidemiology·2026

Association Between Insurance Status on Risk of Stroke Recurrence with Incident Cryptogenic Stroke: A Secondary Analysis of the Cardiac Abnormalities in Stroke Prevention and Recurrence Study.

Neuroepidemiology·2026

Incidence of Multiple Sclerosis in the City of Catania: A 50-Year Observational Population-Based Study.

Neuroepidemiology·2026

Unexpected Conduction Blocks in SORD-Related Distal Motor Neuropathy: A Case Report.

Clinical case reports·2026

Serum Uric Acid in Chronic Kidney Disease as a Marker of Risk or a Modifiable Driver of Progression: A Systematic Review.

Cureus·2026

Immunomodulatory and anti-inflammatory potential of S-nitrosoglutathione (GSNO) in multiple sclerosis: a review of mechanisms and therapeutic perspectives.

Frontiers in immunology·2026

Systematic review of unveiling the potential of AI using machine learning and deep learning methods in neurodegenerative diseases.

PeerJ. Computer science·2026

Amyotrophic lateral sclerosis -plus patient with an intermediate-length CACNA1A allele: a Case Report.

Frontiers in genetics·2026

Silent neurovestibular frailty: a conceptual model integrating vestibular dysfunction, dual-task mobility and cognitive load as candidate contributors to falls, delirium and functional decline in older adults.

Frontiers in aging neuroscience·2026

Related Experiment Videos

Glucose-6-phosphate dehydrogenase deficiency and multiple sclerosis in northern Sardinia

Related Concept Videos

HER-2 gene alterations as biomarker in patients with metastatic colorectal cancer treated with FOLFIRI + cetuximab: findings from the CAPRI-2 GOIM study.

Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial.

Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study.

A multicentre study on spontaneous in-cage activity and micro-environmental conditions of IVC housed C57BL/6J mice during consecutive cycles of bi-weekly cage-change.

NEPA (netupitant/palonosetron) for the antiemetic prophylaxis of nausea and vomiting induced by chemotherapy (CINV) with Folfirinox and Folfoxiri even during the COVID-19 pandemic: a real-life study.

Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial.

Sex disparities in comorbidities, one-year functional outcome and mortality after ischemic stroke: a population-based study.

Early cognitive instability predicts persistent decline: a 10 year longitudinal study in a rural, low resource community.

Trends and Disparities in Dementia- and Sepsis-Related Mortality in Older U.S. Adults (1999-2020).

Residential radon concentration and the risk of malignant brain and central nervous system cancer in United States postmenopausal women.

Association Between Insurance Status on Risk of Stroke Recurrence with Incident Cryptogenic Stroke: A Secondary Analysis of the Cardiac Abnormalities in Stroke Prevention and Recurrence Study.

Incidence of Multiple Sclerosis in the City of Catania: A 50-Year Observational Population-Based Study.

Unexpected Conduction Blocks in SORD-Related Distal Motor Neuropathy: A Case Report.

Serum Uric Acid in Chronic Kidney Disease as a Marker of Risk or a Modifiable Driver of Progression: A Systematic Review.

Immunomodulatory and anti-inflammatory potential of S-nitrosoglutathione (GSNO) in multiple sclerosis: a review of mechanisms and therapeutic perspectives.

Systematic review of unveiling the potential of AI using machine learning and deep learning methods in neurodegenerative diseases.

Amyotrophic lateral sclerosis -plus patient with an intermediate-length CACNA1A allele: a Case Report.

Silent neurovestibular frailty: a conceptual model integrating vestibular dysfunction, dual-task mobility and cognitive load as candidate contributors to falls, delirium and functional decline in older adults.

Related Experiment Videos

Glucose-6-phosphate dehydrogenase deficiency and multiple sclerosis in northern Sardinia

Related Concept Videos

Related Articles